Charles A Riccobono Md is categorized under Internal Medicine Practitioners in Hackensack, NJ and active since 1974.
Charles A Riccobono Md was established in 1974, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Charles A Riccobono at the company’s single location by writing to 20 Prospect Avenue # 915, Hackensack, New Jersey NJ 07601 or by phoning (201) 342-9119. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Charles A Riccobono Md |
Contact Person: | Charles A Riccobono |
Address: | 20 Prospect Avenue # 915, Hackensack, New Jersey 07601 |
Phone Number: | (201) 342-9119 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 1974 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Practitioners |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Charles A Riccobono Md was started in 1974 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Charles A Riccobono for inquiries that concern Charles A Riccobono Md by calling the company number (201) 342-9119, as your correspondence is most welcome. Additionally, the physical location of the single location of Charles A Riccobono Md can be found at the coordinates 40.883618,-74.057978 as well as the street address 20 Prospect Avenue # 915 in Hackensack, New Jersey 07601.
For its online presence, you may visit Charles A Riccobono Md’s website at and engage with its social media outlets through on Twitter and on Facebook.